Correction: Effect of Hepatic Impairment or Renal Impairment on the Pharmacokinetics of Aficamten
- Open Access
- 23.08.2025
- Correction
Erschienen in:
Correction: Clin Pharmacokinet (2025) 64:397–406 https://doi.org/10.1007/s40262-025-01481-9
In this article the word ‘SEQUIOA’ should have read ‘SEQUOIA’ in all the instances mentioned below.
Anzeige
In the sentence beginning ‘The pivotal, phase 3…’ in this article, the term ‘SEQUIOA-HCM (NCT05186818) trial’ should have read ‘SEQUOIA-HCM (NCT05186818) trial’.
In the sentence beginning ‘Pharmacokinetic samples were collected…’, the term ‘SEQUIOA-HCM study’ should have read ‘SEQUOIA-HCM study’.
In the sentence beginning ‘The post hoc aficamten steady-state exposures…’, the term ‘(median last stable dose in SEQUIOA-HCM)’ should have read ‘(median last stable dose in SEQUOIA-HCM)’.
In the sentence beginning ‘A total of 183 patients with oHCM…’, the term ‘phase 3 SEQUIOA-HCM study’ should have read ‘phase 3 SEQUOIA-HCM study’.
Anzeige
The terms ‘SEQUIOA-HCM’ in Table 4 caption and notes, should have read ‘SEQUOIA-HCM’.
In the sentence beginning ‘Of the 543 participants screened…’, the term ‘Phase 3 Study SEQUIOA-HCM’ should have read ‘Phase 3 Study SEQUOIA-HCM’.
The original article has been corrected.
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.